Chemical inhibitors of ZNF416 act through a variety of cellular signaling pathways to achieve functional inhibition. Wortmannin and LY294002 are both inhibitors of phosphatidylinositol 3-kinase (PI3K), a vital component of the PI3K/AKT pathway, which is central to various cellular processes including proliferation and survival. Inhibition of PI3K leads to a downstream reduction in AKT activity, a kinase that, when active, can influence the function of ZNF416. Triciribine targets AKT directly, preventing its activation and subsequent signaling events that would otherwise contribute to the functional activity of ZNF416. By inhibiting this pathway, these chemicals limit the cellular context in which ZNF416 can operate, thereby inhibiting its function.
In addition, the MAPK pathway, which includes a cascade of proteins such as MEK, ERK, JNK, and p38, can be targeted by chemicals such as PD98059, SP600125, U0126, and SB203580 to inhibit ZNF416. PD98059 and U0126 specifically inhibit MEK1/2, which effectively reduces ERK activation, a protein kinase that can be involved in pathways where ZNF416 has a role, leading to ZNF416 inhibition. SP600125 and SB203580 target the JNK and p38 MAP kinases, respectively, which are also part of the MAPK pathway and whose inhibition can disrupt the signaling that may be necessary for ZNF416 function. Src family kinases, which are upstream regulators of various signaling pathways, can be inhibited by chemicals like PP2 and PD173955. By inhibiting Src family kinases, these chemicals disrupt the regulatory pathways that could contribute to the normal function of ZNF416. Another Src kinase inhibitor, Dasatinib, also serves to dampen the activity of kinases that are part of signaling cascades related to the function of ZNF416. Finally, Palbociclib, a CDK4/6 inhibitor, can halt the progression of the cell cycle, which is a process that ZNF416 may influence. The inhibition of CDK4/6 by Palbociclib disrupts the cell cycle-dependent signaling pathways, leading to the inhibition of ZNF416 function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K which ZNF416 utilizes for signal transduction, leading to the functional inhibition of ZNF416. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to mTOR, a kinase that is crucial for cell growth and proliferation pathways where ZNF416 is involved, inhibiting its function. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Specifically inhibits AKT, downstream of PI3K, which ZNF416 may act through, leading to its inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, resulting in blockade of the PI3K/AKT pathway, thereby inhibiting ZNF416 activity downstream. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which is upstream of ERK in the MAPK pathway, a pathway ZNF416 could influence; inhibition of MEK functionally inhibits ZNF416. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, part of the MAPK pathway, which in turn could inhibit ZNF416 function by blocking downstream signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, potentially inhibiting ZNF416 by disrupting its associated signaling pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Selectively inhibits MEK1/2, affecting the MAPK/ERK pathway and thereby inhibiting ZNF416 function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor, which could impede pathways involving ZNF416, leading to its functional inhibition. | ||||||
PD 173955 | 260415-63-2 | sc-507378 | 10 mg | $320.00 | ||
Inhibits Src and Bcr-Abl kinases, which are potentially involved in signaling pathways regulated by ZNF416, thereby inhibiting its function. | ||||||